Promising theranostic approach targets Hard-to-Treat prostate cancer

NCT ID NCT04868604

First seen Dec 29, 2025 · Last updated May 15, 2026 · Updated 19 times

Summary

This study tests a new approach that combines imaging and treatment for men with advanced prostate cancer that no longer responds to hormone therapy. The treatment uses a radioactive substance that targets a protein (PSMA) found on cancer cells. The goal is to see if it is safe and effective at shrinking tumors or slowing the disease. About 54 participants will receive the therapy and be closely monitored.

Disclaimer Read more

This is a summary of the original study . Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.

Get updates

Get notified about this study

Sign up to get updates when this study changes or when new studies for PROSTATIC NEOPLASMS, CASTRATION-RESISTANT are added.

Our safety recommendation!

By submitting, you agree to our Terms of use

Contacts and locations

Study contacts

  • Contact

    Phone: •••-•••-•••• Email: •••••@•••••

Locations

  • BAMF Health

    RECRUITING

    Grand Rapids, Michigan, 49503, United States

    Contact

  • East Jefferson General Hospital

    RECRUITING

    River Ridge, Louisiana, 70123, United States

  • Mayo Clinic

    RECRUITING

    Rochester, Minnesota, 55905, United States

    Contact

  • Stanford Cancer Institute

    RECRUITING

    Stanford, California, 94305, United States

    Contact

    Contact

  • Washington University School of Medicine at Barnes-Jewish Hospital

    RECRUITING

    St Louis, Missouri, 63110, United States

    Contact

  • Weill Cornell Medicine at New York-Presbyterian

    RECRUITING

    New York, New York, 10021, United States

    Contact

  • XCancer

    RECRUITING

    Omaha, Nebraska, 68130, United States

    Contact

    Contact Phone: •••-•••-•••• Email: •••••@•••••

Conditions

Explore the condition pages connected to this study.